Radiation is a mainstay of breast cancer treatment. But a new trial suggests older patients may be able to forego it.February 21, 2023Check out STAT+Sponsored By Gene J. Puskar/AP Experts weigh in on potential health hazards posed by chemicals in Ohio train derailment In the aftermath of Ohio's train disaster, concerns are mounting about potential chemical exposures sustained by humans and wildlife. By Jill Neimark For many older breast cancer patients, study finds radiation doesn't affect survival The findings offer guidance on which women over 65 might safely choose to forgo the side effects of radiation. By Angus Chen STAT+ | Antibody treatment benefits leukemia patients receiving bone marrow transplant The antibody-radiation treatment, called Iomab-B, is being developed by Actinium Pharmaceuticals, a small drugmaker based in New York. By Adam Feuerstein TOLGA AKMEN/AFP/Getty Images Opinion: Tobacco companies pledge 'harm reduction' but are doing the opposite Big Tobacco's "harm reduction" seems to be marketing nicotine-laden vaping products and lobbying against regulating traditional cigarettes. By Howard K. Koh and Michael Fiore STAT+ | Christi Shaw, leader of Gilead's cancer cell therapy unit, to depart Christi Shaw, who took the CEO role in July 2019, was inspired to join Kite in part by the experience of watching her sister fight cancer. By Matthew Herper and Adam Feuerstein More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Cancer Briefing? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments